Symptomatic awareness of hypoglycemia may be less pronounced in patients with longstanding diabetes, in patients with diabetic nerve disease, in patients using medications that block the sympathetic nervous system (e.g., beta-blockers) [see DRUG INTERACTIONS ], or in patients who experience recurrent hypoglycemia
Results may vary To see if GLP-1 resistance translated into therapeutic differences, researchers examined data from several clinical trials of GLP-1 receptor agonists in people with diabetes
There is no FDA-approved patch for a GLP-1, says Natasha Bhuyan, MD, a board-certified family physician at Amazon One Medical in Phoenix
It influences stress-related neurotransmitters like gamma-aminobutyric acid (GABA), promoting calmness and relaxation
Immunity (2012) 36(4):65867